Scopolamine Transdermal System recalls

The FDA has published 1 recall involving Scopolamine Transdermal System since 2018. The latest was reported on 23 May 2018. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls1since 2018

Last 12 months0reported

Class I00% of total

Ongoing0latest 23 May 2018

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 1 100%Class III 0 0%

Why scopolamine transdermal system is recalled

Other Reasons1100%

Companies

L. Perrigo1100%

By year

20181100%

All scopolamine transdermal system recalls, newest first

1 total

Reported	Class	Recall	Company	Reason	Where
23 May 2018Drug	CLASS II	Scopolamine Transdermal Therapeutic System, 1 mg/3 days, a) recalledScopolamine Transdermal System	L. Perrigo	Other	Nationwide

Should you stop taking Scopolamine Transdermal System?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.